MYC and neoplasm: Koga et al. reported that FBXW7 expression may be a key etiological factor driving recurrence‐free survival (RFS) in intermediate or high‐risk patients, when compared to expression levels of c‐Myc, phosphorylated c‐Myc, and NOTCH1 in some tumor subsets.